Table 3 |
||||
|
Body composition, overfat and sarcopenia according to the body fat normality curves measured by DXA |
||||
|
PsA |
Ps |
Control |
P |
|
|
N = 45 |
N = 52 |
N = 98 |
||
|
|
||||
|
TLM (kg) |
35.28 ± 3.96 |
37.45 ± 5.32 |
35.93 ± 4.81 |
0.06 |
|
TBF (%) |
46 ± 5.7* |
43.8 ± 6.2 |
43.4 ± 5.5 |
0.04 |
|
Within normality (%) |
15.6†‡ |
34.6 |
37.8 |
0.02 |
|
Above normality (%) |
84.4†‡ |
65.4 |
62.2 |
0.02 |
|
Overfat (%) |
86.7 || § |
61.5 |
58.2 |
0.03 |
|
Sarcopenia (%) |
11.1 |
5.8 |
6.1 |
0.50 |
|
Obesity-sarcopenia (%) |
11.1 |
3.8 |
4.1 |
0.19 |
|
|
||||
|
DXA, dual X-ray absorptiometry; Ps, psoriasis; PsA,: psoriatic arthritis; TBF, total body fat; TLM, total lean mass. *P = 0.03 (PsA vs. control) †P < 0.05(PsA vs Ps) ‡P < 0.05 (PsA vs control) § P < 0.01 (PsA vs. Ps) || P < 0.01 (PsA vs. control) |
||||
|
Pedreira et al. Arthritis Research & Therapy 2011 13:R16 doi:10.1186/ar3240 |
||||